Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year gross profit growth rate
Latest
-44.28%
↓ 575% vs avg
Percentile
P10
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
9.31%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -44.28% |
| Q2 2025 | 42.02% |
| Q1 2025 | -11.18% |
| Q4 2024 | 105.75% |
| Q3 2024 | -68.81% |
| Q2 2024 | 45.22% |
| Q1 2024 | 19.45% |
| Q4 2023 | 264.99% |
| Q3 2023 | -67.58% |
| Q2 2023 | -1.56% |
| Q1 2023 | 50.52% |
| Q4 2022 | -5.02% |
| Q3 2022 | -47.21% |
| Q2 2022 | -11.98% |
| Q1 2022 | -12.57% |
| Q4 2021 | 41.02% |
| Q3 2021 | -57.93% |
| Q2 2021 | 71.75% |
| Q1 2021 | -30.02% |
| Q4 2020 | 26.24% |
| Q3 2020 | -32.14% |
| Q2 2020 | 20.17% |
| Q1 2020 | 29.22% |
| Q4 2019 | 1.16% |
| Q3 2019 | -41.49% |
| Q2 2019 | 23.54% |
| Q1 2019 | 27.87% |
| Q4 2018 | 1.57% |
| Q3 2018 | -34.15% |
| Q2 2018 | 23.26% |
| Q1 2018 | 27.78% |
| Q4 2017 | -18.32% |
| Q3 2017 | -1.89% |
| Q2 2017 | -16.11% |
| Q1 2017 | 23.63% |
| Q4 2016 | -10.36% |
| Q3 2016 | -7.20% |
| Q2 2016 | 76.20% |
| Q1 2016 | -25.10% |
| Q4 2015 | -3.96% |